Impact of vericiguat on heart failure with reduced ejection fraction: a review
Authors:
- Manisha VohraMVManisha Vohra
- Mohammad AmirMAMohammad Amir
- Ian OsoroIOIan Osoro
- Amit SharmaASAmit Sharma
- Ranjeet KumarRKRanjeet Kumar
Open Access
- 1 September 2023
- journal article
- review article
- Published by KEAI Publishing in Global Health Journal
- Vol. 7 (3) , 123-129
Abstract
No abstract availableFunding Information
- Indo Soviet Friendship College of Pharmacy
This publication has 33 references indexed in Scilit:
- 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive SummaryCirculation, 2013
- Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT StudyEuropean Heart Journal, 2012
- Hypertension, Heart Failure, and Ejection FractionCirculation, 2008
- Systolic and Diastolic Heart Failure in the CommunityJAMA, 2006
- Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based StudyNew England Journal of Medicine, 2006
- Sex-Based Differences in the Effect of Digoxin for the Treatment of Heart FailureNew England Journal of Medicine, 2002
- Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart FailureCirculation, 2002
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)The American Journal of Cardiology, 1988